Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot-Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility

被引:18
作者
Aggarwal, S. K. [1 ]
Carter, G. T. [2 ]
Sullivan, M. D. [3 ,4 ]
Zumbrunnen, C. [5 ]
Morrill, R. [5 ]
Mayer, J. D. [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY 10016 USA
[2] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA USA
[5] Univ Washington, Dept Geog, Seattle, WA 98195 USA
[6] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[7] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[8] Univ Washington, Dept Med, Seattle, WA USA
[9] Univ Washington, Dept Family Med, Seattle, WA 98195 USA
[10] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
基金
美国国家科学基金会;
关键词
complementary and alternative medicine; cannabinoid medicine; medical cannabis; cannabinopathic medicine; health-related quality of life; symptom management; SF-36; CDC HRQoL-14;
D O I
10.1177/1049909112454215
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To characterize health-related quality of life (HRQoL) in medical cannabis patients. Methods: Short Form 36 (SF-36) Physical Health Component Score and Mental Health Component Score (MCS) surveys as well has CDC (Centers for Disease Control) HRQoL-14 surveys were completed by 37 qualified patients. Results: Mean SF-36 PCS and MCS, normalized at 50, were 37.4 and 44.2, respectively. Eighty percent of participants reported activity/functional limitations secondary to impairments or health problems. Patients reported using medical cannabis to treat a wide array of symptoms across multiple body systems with relief ratings consistently in the 7-10/10 range. Conclusion: The HRQoL results in this sample of medical cannabis-using patients are comparable with published norms in other chronically ill populations. Data presented provide insight into medical cannabis-using patients' self-rated health, HRQoL, disease incidences, and cannabis-related symptom relief.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 28 条
[11]  
JIMENEZ A, A JIMENEZS FOLLOW UP
[12]   Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment [J].
Leon, Andrew C. ;
Hedeker, Donald ;
Teres, Jedediah J. .
STATISTICS IN MEDICINE, 2007, 26 (01) :110-123
[13]   Health status assessment methods for adults: Past accomplishments and future challenges [J].
McHorney, CA .
ANNUAL REVIEW OF PUBLIC HEALTH, 1999, 20 :309-335
[14]   The Centers for Disease Control and Prevention's Healthy Days Measures – Population tracking of perceived physical and mental health over time [J].
David G Moriarty ;
Mathew M Zack ;
Rosemarie Kobau .
Health and Quality of Life Outcomes, 1 (1)
[15]  
*OFM, INT POSTC EST COUNT
[16]  
ONDCP, 2008, 2008 MAR SOURC MAR G
[17]  
*OR MED MAR PROGR, OR MED MAR PROGR OMM
[18]   The endocannabinoid system as an emerging target of pharmacotherapy [J].
Pacher, Pal ;
Batkai, Sandor ;
Kunos, George .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :389-462
[19]   Cannabis as a substitute for alcohol and other drugs [J].
Reiman, Amanda .
HARM REDUCTION JOURNAL, 2009, 6
[20]  
REINMAN A, 2006, THESIS U CALIFORNIA